Impact of COVID-19 Outbreak on Genome-Based Drug, Global Market Research Report 2020

1 Genome-Based Drug Market Overview

• 1.1 Product Overview and Scope of Genome-Based Drug
• 1.2 Covid-19 Impact on Genome-Based Drug Segment by Type
  • 1.2.1 Global Genome-Based Drug Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Insulin
  • 1.2.3 Growth Hormone
  • 1.2.4 Monoclonal Antibody
  • 1.2.5 Other
• 1.3 Covid-19 Impact on Genome-Based Drug Segment by Application
  • 1.3.1 Genome-Based Drug Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Hospital
  • 1.3.3 Pharmaceutical Factory
  • 1.3.4 Other
• 1.4 Covid-19 Impact on Global Genome-Based Drug Market Size Estimates and Forecasts
  • 1.4.1 Global Genome-Based Drug Revenue 2015-2026
  • 1.4.2 Global Genome-Based Drug Sales 2015-2026
  • 1.4.3 Genome-Based Drug Market Size by Region: 2020 Versus 2026
• 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  • 1.5.2 Covid-19 Impact: Commodity Prices Indices
  • 1.5.3 Covid-19 Impact: Global Major Government Policy
• 1.6 The Covid-19 Impact on Genome-Based Drug Industry
• 1.7 COVID-19 Impact: Genome-Based Drug Market Trends

2 Covid-19 Impact on Global Genome-Based Drug Market Competition by Manufacturers

• 2.1 Global Genome-Based Drug Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Genome-Based Drug Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Genome-Based Drug Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Genome-Based Drug Manufacturing Sites, Area Served, Product Type
• 2.5 Genome-Based Drug Market Competitive Situation and Trends
  • 2.5.1 Genome-Based Drug Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Genome-Based Drug Players (Opinion Leaders)

3 Covid-19 Impact on Genome-Based Drug Retrospective Market Scenario by Region

• 3.1 Global Genome-Based Drug Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Genome-Based Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Genome-Based Drug Market Facts & Figures by Country
  • 3.3.1 North America Genome-Based Drug Sales by Country
  • 3.3.2 North America Genome-Based Drug Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Genome-Based Drug Market Facts & Figures by Country
  • 3.4.1 Europe Genome-Based Drug Sales by Country
  • 3.4.2 Europe Genome-Based Drug Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Genome-Based Drug Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Genome-Based Drug Sales by Region
  • 3.5.2 Asia Pacific Genome-Based Drug Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Genome-Based Drug Market Facts & Figures by Country
  • 3.6.1 Latin America Genome-Based Drug Sales by Country
  • 3.6.2 Latin America Genome-Based Drug Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Genome-Based Drug Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Genome-Based Drug Sales by Country
  • 3.7.2 Middle East and Africa Genome-Based Drug Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Covid-19 Impact on Global Genome-Based Drug Historic Market Analysis by Type

• 4.1 Global Genome-Based Drug Sales Market Share by Type (2015-2020)
• 4.2 Global Genome-Based Drug Revenue Market Share by Type (2015-2020)
• 4.3 Global Genome-Based Drug Price Market Share by Type (2015-2020)
• 4.4 Global Genome-Based Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Covid-19 Impact on Global Genome-Based Drug Historic Market Analysis by Application

• 5.1 Global Genome-Based Drug Sales Market Share by Application (2015-2020)
• 5.2 Global Genome-Based Drug Revenue Market Share by Application (2015-2020)
• 5.3 Global Genome-Based Drug Price by Application (2015-2020)

6 Company Profiles and Key Figures in Genome-Based Drug Business

• 6.1 Sandoz International
  • 6.1.1 Corporation Information
  • 6.1.2 Sandoz International Description, Business Overview and Total Revenue
  • 6.1.3 Sandoz International Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Sandoz International Products Offered
  • 6.1.5 Sandoz International Recent Development and Response to COVID-19
• 6.2 Teva pharmaceutical industries
  • 6.2.1 Teva pharmaceutical industries Corporation Information
  • 6.2.2 Teva pharmaceutical industries Description, Business Overview and Total Revenue
  • 6.2.3 Teva pharmaceutical industries Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Teva pharmaceutical industries Products Offered
  • 6.2.5 Teva pharmaceutical industries Recent Development and Response to COVID-19
• 6.3 Mylan
  • 6.3.1 Mylan Corporation Information
  • 6.3.2 Mylan Description, Business Overview and Total Revenue
  • 6.3.3 Mylan Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Mylan Products Offered
  • 6.3.5 Mylan Recent Development and Response to COVID-19
• 6.4 3SBio
  • 6.4.1 3SBio Corporation Information
  • 6.4.2 3SBio Description, Business Overview and Total Revenue
  • 6.4.3 3SBio Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 3SBio Products Offered
  • 6.4.5 3SBio Recent Development and Response to COVID-19
• 6.5 Shanghai Fosun Pharmaceutical
  • 6.5.1 Shanghai Fosun Pharmaceutical Corporation Information
  • 6.5.2 Shanghai Fosun Pharmaceutical Description, Business Overview and Total Revenue
  • 6.5.3 Shanghai Fosun Pharmaceutical Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Shanghai Fosun Pharmaceutical Products Offered
  • 6.5.5 Shanghai Fosun Pharmaceutical Recent Development and Response to COVID-19
• 6.6 Tonghua Dongbao Pharmaceutical
  • 6.6.1 Tonghua Dongbao Pharmaceutical Corporation Information
  • 6.6.2 Tonghua Dongbao Pharmaceutical Description, Business Overview and Total Revenue
  • 6.6.3 Tonghua Dongbao Pharmaceutical Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Tonghua Dongbao Pharmaceutical Products Offered
  • 6.6.5 Tonghua Dongbao Pharmaceutical Recent Development and Response to COVID-19
• 6.7 Biocon
  • 6.6.1 Biocon Corporation Information
  • 6.6.2 Biocon Description, Business Overview and Total Revenue
  • 6.6.3 Biocon Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Biocon Products Offered
  • 6.7.5 Biocon Recent Development and Response to COVID-19
• 6.8 Reliance Life Sciences
  • 6.8.1 Reliance Life Sciences Corporation Information
  • 6.8.2 Reliance Life Sciences Description, Business Overview and Total Revenue
  • 6.8.3 Reliance Life Sciences Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Reliance Life Sciences Products Offered
  • 6.8.5 Reliance Life Sciences Recent Development and Response to COVID-19
• 6.9 Probiomed
  • 6.9.1 Probiomed Corporation Information
  • 6.9.2 Probiomed Description, Business Overview and Total Revenue
  • 6.9.3 Probiomed Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Probiomed Products Offered
  • 6.9.5 Probiomed Recent Development and Response to COVID-19
• 6.10 Biosidus
  • 6.10.1 Biosidus Corporation Information
  • 6.10.2 Biosidus Description, Business Overview and Total Revenue
  • 6.10.3 Biosidus Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Biosidus Products Offered
  • 6.10.5 Biosidus Recent Development and Response to COVID-19
• 6.11 AMEGA Biotech
  • 6.11.1 AMEGA Biotech Corporation Information
  • 6.11.2 AMEGA Biotech Genome-Based Drug Description, Business Overview and Total Revenue
  • 6.11.3 AMEGA Biotech Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 AMEGA Biotech Products Offered
  • 6.11.5 AMEGA Biotech Recent Development and Response to COVID-19
• 6.12 Celltrion
  • 6.12.1 Celltrion Corporation Information
  • 6.12.2 Celltrion Genome-Based Drug Description, Business Overview and Total Revenue
  • 6.12.3 Celltrion Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.12.4 Celltrion Products Offered
  • 6.12.5 Celltrion Recent Development and Response to COVID-19
• 6.13 LG Life Science
  • 6.13.1 LG Life Science Corporation Information
  • 6.13.2 LG Life Science Genome-Based Drug Description, Business Overview and Total Revenue
  • 6.13.3 LG Life Science Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.13.4 LG Life Science Products Offered
  • 6.13.5 LG Life Science Recent Development and Response to COVID-19
• 6.14 Dong-A Pharmaceutical
  • 6.14.1 Dong-A Pharmaceutical Corporation Information
  • 6.14.2 Dong-A Pharmaceutical Genome-Based Drug Description, Business Overview and Total Revenue
  • 6.14.3 Dong-A Pharmaceutical Genome-Based Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.14.4 Dong-A Pharmaceutical Products Offered
  • 6.14.5 Dong-A Pharmaceutical Recent Development and Response to COVID-19

7 Genome-Based Drug Manufacturing Cost Analysis

• 7.1 Genome-Based Drug Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Genome-Based Drug
• 7.4 Genome-Based Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Genome-Based Drug Distributors List
• 8.3 Genome-Based Drug Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Genome-Based Drug Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Genome-Based Drug by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Genome-Based Drug by Type (2021-2026)
• 10.2 Genome-Based Drug Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Genome-Based Drug by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Genome-Based Drug by Application (2021-2026)
• 10.3 Genome-Based Drug Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Genome-Based Drug by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Genome-Based Drug by Region (2021-2026)
• 10.4 North America Genome-Based Drug Estimates and Projections (2021-2026)
• 10.5 Europe Genome-Based Drug Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Genome-Based Drug Estimates and Projections (2021-2026)
• 10.7 Latin America Genome-Based Drug Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Genome-Based Drug Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List